2016-03-05T00:00:00.000-05:00
refractory epilepsy,-0.406274
Piper Jaffray,0.239037
product candidates,0.201963
Exchange Commission,0.532163
email newsletter,0.566987
specialty pharmaceutical company,0.233095
recent quarter,0.219424
synthetic cannabinoid therapeutics,0.447354
Thursday,-0.163731
email address,0.505807
related companies,0.566987
InvestorPlace Broker Center,0.555736
high fees,-0.735674
research report,0.336097
sell rating,0.37303
peripheral neuropathic pain,-0.645159
personal trading style,0.598412
transdermal delivery,0.447354
recent disclosure,0.532163
investment analyst,0.37303
latest news,0.505807
Emerald Advisers,0.285163
target price,0.0594771
average rating,-0.247964
Pharmaceuticals Inc Daily,0.397938
buy rating,0.37303
research note,0.200335
shares,-0.078329
concise daily summary,0.505807
consensus target price,0.440905
Fragile X syndrome,-0.484886
Analyst Ratings Network.com,-0.338144
stock broker,0.245696
Zynerba Pharmaceuticals,0.0830136
cannabinoid therapeutics,0.447354
